[1]
|
World Health Organization (2023) Obesity and Overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
|
[2]
|
Ng, M., Fleming, T., Robinson, M., et al. (2014) Global, Regional, and National Prevalence of Overweight and Obesity in Children and Adults during 1980-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 384, 766-781.
|
[3]
|
Engin, A. (2017) The Definition and Prevalence of Obesity and Metabolic Syndrome. In: Engin, A. and Engin, A., Eds., Obesity and Lipotoxicity, Springer International Publishing, 1-17. https://doi.org/10.1007/978-3-319-48382-5_1
|
[4]
|
Hruby, A. and Hu, F.B. (2014) The Epidemiology of Obesity: A Big Picture. PharmacoEconomics, 33, 673-689. https://doi.org/10.1007/s40273-014-0243-x
|
[5]
|
安琪尔, 陈燕燕. 肥胖相关性心力衰竭的研究进展[J]. 中国循环杂志, 2024, 39(1): 89-94.
|
[6]
|
乔芳伟, 王晓辉, 梁阔, 等. 肥胖和肿瘤关系的研究进展[J]. 中国临床医生杂志, 2018, 46(11): 1279-1282.
|
[7]
|
孙艺, 王瑞楠, 韩宇博, 等. 基于网络药理学的中药治疗肥胖的机制研究进展[J]. 实用药物与临床, 2024, 27(5): 380-386.
|
[8]
|
Chen, Y., Liu, T., Teia, F.K.F. and Xie, M. (2023) Exploring the Underlying Mechanisms of Obesity and Diabetes and the Potential of Traditional Chinese Medicine: An Overview of the Literature. Frontiers in Endocrinology, 14, Article 121880. https://doi.org/10.3389/fendo.2023.1218880
|
[9]
|
Zhang, H., Tian, J., Lian, F., Li, M., Liu, W., Zhen, Z., et al. (2021) Therapeutic Mechanisms of Traditional Chinese Medicine to Improve Metabolic Diseases via the Gut Microbiota. Biomedicine & Pharmacotherapy, 133, Article 110857. https://doi.org/10.1016/j.biopha.2020.110857
|
[10]
|
贾雅甜, 张倩, 王慧, 等. 中药对肥胖病人干预有效性和安全性的系统评价再评价[J]. 全科护理, 2024, 22(10): 1789-1794.
|
[11]
|
Chen, C., Li, X., Kano, Y., Yuan, D. and Qu, J. (2023) Oriental Traditional Herbal Medicine—Puerariae Flos: A Systematic Review. Journal of Ethnopharmacology, 306, Article 116089. https://doi.org/10.1016/j.jep.2022.116089
|
[12]
|
Wang, S., Zhang, S., Wang, S., Gao, P. and Dai, L. (2020) A Comprehensive Review on Pueraria: Insights on Its Chemistry and Medicinal Value. Biomedicine & Pharmacotherapy, 131, Article 110734. https://doi.org/10.1016/j.biopha.2020.110734
|
[13]
|
李蓉, 宋宗良, 张效科, 等. 葛根现代药理作用及复方临床应用研究进展[J]. 海南医学院学报, 2023, 29(2): 153-160.
|
[14]
|
Yang, C., Liu, H., Chang, Z., Liu, G., Chang, H., Huang, P., et al. (2024) Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice. International Journal of Molecular Sciences, 25, Article 5274. https://doi.org/10.3390/ijms25105274
|
[15]
|
Wong, K.H., Li, G.Q., Li, K.M., Razmovski-Naumovski, V. and Chan, K. (2011) Kudzu Root: Traditional Uses and Potential Medicinal Benefits in Diabetes and Cardiovascular Diseases. Journal of Ethnopharmacology, 134, 584-607. https://doi.org/10.1016/j.jep.2011.02.001
|
[16]
|
陈凯, 魏平慧, 史琳. 葛根异黄酮类成分的药理作用研究进展[J]. 药物评价研究, 2022, 45(12): 2602-2610.
|
[17]
|
木盼盼, 安琪, 张彦昭, 等. 一测多评法测定葛根药材中9个异黄酮成分的含量[J]. 中国中药杂志, 2019, 44(22): 4888-4895.
|
[18]
|
杨欣, 李亚辉, 钱海兵. 中药葛根化学成分-靶标蛋白-通路-疾病关联性分析[J]. 中医药导报, 2019, 25(2): 76-82.
|
[19]
|
Hu, Q., Xiang, H., Shan, J., Jiao, Q., Lv, S., Li, L., et al. (2020) Two Pairs of Diastereoisomeric Isoflavone Glucosides from the Roots of Pueraria lobata. Fitoterapia, 144, Article 104594. https://doi.org/10.1016/j.fitote.2020.104594
|
[20]
|
吴萍, 祁俊, 张袁祥. UPLC法测定葛根中9个化学成分的含量[J]. 现代中药研究与实践, 2024, 38(2): 48-52.
|
[21]
|
宋玮, 李艳姣, 乔雪, 等. 中药葛根的化学成分研究进展(英文) [J]. 中国药学(英文版), 2014, 23(6): 347-360.
|
[22]
|
范淼崟, 刘荣华, 邵峰, 等. 葛根化学成分研究[J]. 中药材, 2022, 45(8): 1877-1885.
|
[23]
|
Arao, T., Kinjo, J., Nohara, T. and Isobe, R. (1997) Oleanene-Type Triterpene Glycosides from Puerariae Radix. IV. Six New Saponins from Pueraria lobata. Chemical and Pharmaceutical Bulletin, 45, 362-366. https://doi.org/10.1248/cpb.45.362
|
[24]
|
卢紫君, 蔡芳, 王少华, 等. 野葛与粉葛淀粉的结构及物化特性比较[J]. 现代食品科技, 2021, 37(8): 109-118.
|
[25]
|
董洲. 野葛根多糖的提取、分离纯化、结构鉴定及对小鼠巨噬细胞RAW264.7的免疫调节活性研究[D]: [硕士学位论文]. 华南理工大学, 2018.
|
[26]
|
陈艳, 文佳玉, 谢晓芳, 等. 葛根的化学成分及药理作用研究进展[J]. 中药与临床, 2021, 12(1): 53-60.
|
[27]
|
Lee, O., Seo, D., Park, C. and Kim, Y. (2010) Puerarin Enhances Adipocyte Differentiation, Adiponectin Expression, and Antioxidant Response in 3T3‐L1 Cells. BioFactors, 36, 459-467. https://doi.org/10.1002/biof.119
|
[28]
|
Pham, T.H., Lee, G.H., Jin, S.W., Lee, S.Y., Han, E.H., Kim, N.D., et al. (2022) Puerarin Attenuates Hepatic Steatosis via G‐Protein‐Coupled Estrogen Receptor‐Mediated Calcium and SIRT1 Signaling Pathways. Phytotherapy Research, 36, 3601-3618. https://doi.org/10.1002/ptr.7526
|
[29]
|
Jung, H., Kang, A., Kang, S., Park, Y. and Song, M. (2017) The Root Extract of Pueraria lobata and Its Main Compound, Puerarin, Prevent Obesity by Increasing the Energy Metabolism in Skeletal Muscle. Nutrients, 9, Article 33. https://doi.org/10.3390/nu9010033
|
[30]
|
Luo, D., Dong, X., Huang, J., Huang, C., Fang, G. and Huang, Y. (2021) Pueraria lobata Root Polysaccharide Alleviates Glucose and Lipid Metabolic Dysfunction in Diabetic db/db Mice. Pharmaceutical Biology, 59, 380-388. https://doi.org/10.1080/13880209.2021.1898648
|
[31]
|
Zhu, H.-Y., Liu, Y., Li, J.-R., Liu, Y.-H., Rong, Z.-L., Li, Y.-T., et al. (2023) Effect and Mechanism of Puerariae Lobatae Radix in Alleviating Insulin Resistance in T2DM db/db Mice Based on Intestinal Flora. China Journal of Chinese Materia Medica, 48, 4693-4701.
|
[32]
|
Buhlmann, E., Horváth, C., Houriet, J., Kiehlmann, E., Radtke, J., Marcourt, L., et al. (2019) Puerariae Lobatae Root Extracts and the Regulation of Brown Fat Activity. Phytomedicine, 64, Article 153075. https://doi.org/10.1016/j.phymed.2019.153075
|
[33]
|
Chen, X., Yu, J. and Shi, J. (2018) Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone from Pueraria lobata. The American Journal of Chinese Medicine, 46, 1771-1789. https://doi.org/10.1142/s0192415x18500891
|
[34]
|
Xu, X., Guo, Y., Chen, S., Ma, W., Xu, X., Hu, S., et al. (2022) The Positive Influence of Polyphenols Extracted from Pueraria lobata Root on the Gut Microbiota and Its Antioxidant Capability. Frontiers in Nutrition, 9, Article 868188. https://doi.org/10.3389/fnut.2022.868188
|
[35]
|
Shin, H.-J., Yoo, J.-E., Jung, E.-H., Yoo, D.-Y., et al. (2012) Effects of Pueraria lobata on Body Weight and Gene Expression in Obese Rats Muscle with Estrogen Deficiency. The Journal of Korean Obstetrics and Gynecology, 25, 71-84.
|
[36]
|
Wang, L., Wu, Y., Zhuang, L., Chen, X., Min, H., Song, S., et al. (2019) Puerarin Prevents High-Fat Diet-Induced Obesity by Enriching Akkermansia muciniphila in the Gut Microbiota of Mice. PLOS ONE, 14, e0218490. https://doi.org/10.1371/journal.pone.0218490
|
[37]
|
Choi, Y., Bose, S., Shin, N.R., Song, E., Nam, Y. and Kim, H. (2020) Lactate-Fortified Puerariae Radix Fermented by Bifidobacterium Breve Improved Diet-Induced Metabolic Dysregulation via Alteration of Gut Microbial Communities. Nutrients, 12, Article 276. https://doi.org/10.3390/nu12020276
|
[38]
|
Zhang, S., Ge, Q., Chen, L. and Chen, K. (2021) Studies of the Anti-Diabetic Mechanism of Pueraria lobata Based on Metabolomics and Network Pharmacology. Processes, 9, Article 1245. https://doi.org/10.3390/pr9071245
|
[39]
|
Baek, S., Baek, J.Y., Kang, K. and Yoo, J. (2017) Effects of Pueraria lobata on Obesity Related Hormones in Rats with Estrogen Deficiency. Journal of Korean Medicine for Obesity Research, 17, 111-118. https://doi.org/10.15429/jkomor.2017.17.2.111
|
[40]
|
Lyu, Q., Xue, W., Liu, R., Ma, Q., Kasaragod, V.B., Sun, S., et al. (2024) A Brain-to-Gut Signal Controls Intestinal Fat Absorption. Nature, 634, 936-943. https://doi.org/10.1038/s41586-024-07929-5
|
[41]
|
江道合, 江青东. 葛根素对肥胖相关基因NPY、POMC和NMU表达的影响[J]. 现代牧业, 2022, 6(3): 5-9.
|
[42]
|
Wang, Z., Du, H., Peng, W., Yang, S., Feng, Y., Ouyang, H., et al. (2022) Efficacy and Mechanism of Pueraria lobata and Pueraria thomsonii Polysaccharides in the Treatment of Type 2 Diabetes. Nutrients, 14, Article 3926. https://doi.org/10.3390/nu14193926
|
[43]
|
孙小鑫, 苗青, 王瑞海, 等. 丹参-葛根药对成分、药理及临床应用的研究进展[J]. 世界科学技术-中医药现代化, 2020, 22(12): 4308-4313.
|
[44]
|
Fong, C.C., Wei, F., Chen, Y., Yu, W.K., Koon, C.M., Leung, P.C., et al. (2011) Danshen-Gegen Decoction Exerts Proliferative Effect on Rat Cardiac Myoblasts H9c2 via MAPK and Insulin Pathways. Journal of Ethnopharmacology, 138, 60-66. https://doi.org/10.1016/j.jep.2011.08.027
|
[45]
|
罗小文. 葛根丹参药对抗动脉粥样硬化作用及机制研究[D]: [硕士学位论文]. 成都: 西南民族大学, 2013.
|
[46]
|
杨雪, 周飞, 杨炀, 等. 葛根素联合丹参酮ⅡA对糖尿病血管病变大鼠t-PA, PAI-1及氧化应激的影响[J]. 中国实验方剂学杂志, 2019, 25(19): 46-54.
|
[47]
|
Shen, P., Liu, M., Ng, T., Chan, Y. and Yong, E.L. (2006) Differential Effects of Isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the Activation of PPARα, PPARγ, and Adipocyte Differentiation in vitro. The Journal of Nutrition, 136, 899-905. https://doi.org/10.1093/jn/136.4.899
|
[48]
|
胡玲美, 范颖, 刘倩, 等. 黄芪葛根配伍对糖尿病大鼠肝组织PI3K/AKT信号通路影响[J]. 辽宁中医药大学学报, 2020, 22(7): 48-51.
|
[49]
|
魏爽, 李冀, 付强, 等. 黄芪-葛根药对通过PI3K/Akt/FoxO1通路调控糖异生作用治疗糖尿病大鼠作用机制[J]. 中华中医药学刊, 2022, 40(8): 32-38, 260.
|
[50]
|
贾云泷. 黄芪-葛根配伍对高脂大鼠胰岛素抵抗(STAT3)影响的研究[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2022.
|
[51]
|
周遵明, 谭梅傲, 彭冲, 等. 黄芪葛根汤对高脂血症大鼠脂质代谢和氧化应激的影响[J]. 中国中西医结合杂志, 2022, 42(2): 195-201.
|
[52]
|
李吉庆, 林道斌, 张永杰. 黄连-葛根药对治疗2型糖尿病的网络药理学研究[J]. 世界中医药, 2021, 16(6): 896-900.
|
[53]
|
赵兴冉, 李佳川, 谭睿, 等. 葛根-黄连药对改善不同糖尿病模型糖脂代谢研究[J]. 中药药理与临床, 2015, 31(2): 49-51.
|
[54]
|
汪群红, 何贤君, 胡敏, 等. 黄连和葛根联合抗糖尿病的药效学研究[J]. 中华中医药学刊, 2019, 37(3): 676-679.
|
[55]
|
章雷, 顾健, 李佳川, 等. 葛根黄连有效组分配伍对STZ复合高脂大鼠2型糖尿病模型的防治作用[J]. 西南民族大学学报(自然科学版), 2016, 42(1): 61-66.
|
[56]
|
王雪. 青钱柳-葛根-桑叶组方对2型糖尿病大鼠模型的治疗作用及机制初探[D]: [硕士学位论文]. 福州: 福建师范大学, 2023.
|
[57]
|
刘文虎, 王斯慧, 曾凡骏. 葛根、桑叶、山药3种天然产物对α-淀粉酶抑制作用研究[J]. 食品工业, 2012, 33(10): 111-113.
|
[58]
|
王琳琳, 胡可佳. 葛根芩连汤对肥胖小鼠的脂质代谢的作用及其机制研究[J]. 世界中西医结合杂志, 2021, 16(7): 1231-1236, 1243.
|
[59]
|
姜丽, 张文彤, 熊艳玲, 等. 葛根芩连汤对肥胖型2型糖尿病前期大鼠慢性缺氧的干预机制[J]. 时珍国医国药, 2023, 34(5): 1064-1068.
|
[60]
|
熊兴江. 葛根芩连汤方证及其在糖尿病、高血压病、高脂血症、肥胖中的运用[J]. 中国中药杂志, 2020, 45(12): 2760-2764.
|
[61]
|
龚凡, 邱艳, 陈清光, 等. 葛根芩连汤对高脂饲养小鼠代谢的影响[J]. 上海中医药杂志, 2017, 51(S1): 168-171.
|
[62]
|
李津, 刘亚明. 复方葛根胶囊对肥胖大鼠体质量血脂及胰岛素瘦素水平的影响[J]. 山西医药杂志, 2009, 38(4): 291-293.
|
[63]
|
葛瑞环. 二陈汤合葛根汤加减联合达英-35治疗痰湿阻滞肥胖型PCOS的临床疗效观察[D]: [硕士学位论文]. 唐山: 华北理工大学, 2021.
|